Related references
Note: Only part of the references are listed.S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas
Jia-Huei Tsai et al.
HISTOPATHOLOGY (2012)
S100P Dissociates Myosin IIA Filaments and Focal Adhesion Sites to Reduce Cell Adhesion and Enhance Cell Migration
Min Du et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Calcium-binding protein S100P and cancer: mechanisms and clinical relevance
Hongfei Jiang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration
Changhua Zhou et al.
BREAST CANCER RESEARCH (2012)
Different roles of S100P Overexpression in Intrahepatic Cholangiocarcinoma: Carcinogenesis of Perihilar Type and Aggressive Behavior of Peripheral Type
Shinichi Aishima et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma
Shin Hamada et al.
CANCER SCIENCE (2011)
Role of p53 and β-catenin Mutations in Conjunction with CK19 Expression on Early Tumor Recurrence and Prognosis of Hepatocellular Carcinoma
Ray-Hwang Yuan et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
The induction of S100p expression by the Prostaglandin E2 (PGE2)/EP4 receptor signaling pathway in colon cancer cells
Anupama Chandramouli et al.
CANCER BIOLOGY & THERAPY (2010)
Identification of Hypermethylated Genes Associated with Cisplatin Resistance in Human Cancers
Xiaofei Chang et al.
CANCER RESEARCH (2010)
Functional evidence implicating S100P in prostate cancer progression
Gargi D. Basu et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Characterization of the Ca2+-regulated Ezrin-S100P Interaction and Its Role in Tumor Cell Migration
Judith Austermann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The calcium-binding protein S100P in normal and malignant human tissues
Seppo Parkkila et al.
BMC CLINICAL PATHOLOGY (2008)
Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma
Ray-Hwang Yuan et al.
CLINICAL CANCER RESEARCH (2007)
S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: Impairment by advanced tumour stages and neoadjuvant chemotherapy
Babett Bartling et al.
EUROPEAN JOURNAL OF CANCER (2007)
RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways
Maren K. Fuentes et al.
DISEASES OF THE COLON & RECTUM (2007)
Unfavourable prognostic significance of S100P expression in ovarian cancers
P. Surowiak et al.
HISTOPATHOLOGY (2007)
Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma
Y. -C. Lee et al.
EUROPEAN JOURNAL OF CANCER (2007)
Smooth muscle actin and s100p on non germinal centre diffuse large B cell lymphoma are adverse prognostic factors: pilot study
Howayda Abd El All
DIAGNOSTIC PATHOLOGY (2007)
Role of L2DTL, cell cycle-regulated nuclear and centrosome protein, in aggressive hepatocellular carcinoma
Hung-Wei Pan et al.
CELL CYCLE (2006)
S100P is an early developmental marker of pancreatic carcinogenesis
Kenoki Ohuchida et al.
CLINICAL CANCER RESEARCH (2006)
Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma
R-H Yuan et al.
JOURNAL OF PATHOLOGY (2006)
Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients
GZ Wang et al.
CANCER RESEARCH (2006)
S100P promotes pancreatic cancer growth, survival, and invasion
T Arumugam et al.
CLINICAL CANCER RESEARCH (2005)
Opposite roles of human pancreatitis-associated protein and REGIA expression in hepatocellular carcinoma:: Association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, β-catenin mutation, and favorable prognosis
RH Yuan et al.
CLINICAL CANCER RESEARCH (2005)
Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer
SE Dowen et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells
HL Hsieh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE)
T Arumugam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
High α-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma:: Significance of hepatitis virus infection, age, p53 and β-catenin mutations
SY Peng et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent
T Crnogorac-Jurcevic et al.
JOURNAL OF PATHOLOGY (2003)
Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma
HW Pan et al.
CANCER (2003)
Ca2+-dependent binding and activation of dormant ezrin by dimeric, S100P
M Koltzscher et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family
A Filipek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
S100P expression in human esophageal epithelial cells: Human esophageal epithelial cells sequentially produce different S100 proteins in the process of differentiation
N Sato et al.
ANATOMICAL RECORD (2002)
Hepatocellular carcinoma: Diagnosis and treatment
AS Befeler et al.
GASTROENTEROLOGY (2002)
Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis
P Laurent-Puig et al.
GASTROENTEROLOGY (2001)
beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis
HC Hsu et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
